Cooper Companies (COO) Restructuring Costs (2009 - 2010)
Cooper Companies (COO) posted Restructuring Costs of $750000.0 for Q4 2010, up 5257.14% on a QoQ basis from $14000.0 in Q3 2010, and up 59.24% year-over-year from $471000.0 in Q4 2009.
Powered by 
Analysis
Cooper Companies (COO) Restructuring Costs (2009 - 2010) Analysis & Trends
Cooper Companies has reported Restructuring Costs for 2 years, with the latest figure at $750000.0 in Q4 2010.
- On a quarterly basis, Restructuring Costs rose 59.24% year-over-year to $750000.0 in Q4 2010; TTM through Jul 2011 was $750000.0, a 97.31% decrease from a year earlier, with the FY2010 full-year figure at $27.8 million, up 613.92% from the prior year.
- Restructuring Costs was $750000.0 for Q4 2010 at Cooper Companies, up from $14000.0 in the prior quarter.
- The five-year high for Restructuring Costs was $27.0 million in Q2 2010, with the low at $14000.0 in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2010 | 750,000.00 |
| Jul 31, 2010 | 14,000.00 |
| Apr 30, 2010 | 27.00 Mn |
| Jan 31, 2010 | 363,000.00 |
| Oct 31, 2009 | 471,000.00 |
| Jul 31, 2009 | 462,000.00 |